Among the various end users of cloud-based drug discovery platforms, pharmaceutical vendors are likely to be major stakeholders holding a high value share of the global cloud-based drug discovery platform market. An opportunity analysis of the global market reveals that leading software vendors have already adopted cloud-based drug discovery platforms to facilitate seamless research and development processes. As there is less adoption of these cloud-based platforms in several countries of the MEA, public and private ventures are taking initiatives to invest in the R&D process in this region. Moreover, the MEA cloud-based drug discovery platform revolution will witness significant growth in the coming years, thereby creating better opportunities for software vendors for growth and expansion.
This report contains market size and forecasts of Cloud-Based Drug Discovery Platforms in Global, including the following market information:
- Global Cloud-Based Drug Discovery Platforms Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Cloud-Based Drug Discovery Platforms market was valued at 997.3 million in 2021 and is projected to reach US$ 1630.3 million by 2028, at a CAGR of 7.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
IaaS Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cloud-Based Drug Discovery Platforms include IBM, Accenture, Tata Consultancy Services, SAS Institute, BioXcel, Cloud Pharmaceuticals, WuXi AppTec, Dassault System and Acelot. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cloud-Based Drug Discovery Platforms companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cloud-Based Drug Discovery Platforms Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cloud-Based Drug Discovery Platforms Market Segment Percentages, by Type, 2021 (%)
Global Cloud-Based Drug Discovery Platforms Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cloud-Based Drug Discovery Platforms Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Pharmaceutical Companies
- Others
Global Cloud-Based Drug Discovery Platforms Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cloud-Based Drug Discovery Platforms Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Cloud-Based Drug Discovery Platforms revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Cloud-Based Drug Discovery Platforms revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- IBM
- Accenture
- Tata Consultancy Services
- SAS Institute
- BioXcel
- Cloud Pharmaceuticals
- WuXi AppTec
- Dassault System
- Acelot
